NATIONAL
CANCER
INSTITUTE

NCI Cancer Bulletin
A Trusted Source for Cancer Research News
August 2, 2005 • Volume 2 / Number 31 E-Mail This Document  |  Download PDF  |  Bulletin Archive/Search  |  Subscribe


Bulletin Home

Featured Article
Combination Hormone/Vaccine Therapy May Benefit Prostate Cancer Patients

Director's Update
Nanotech and Proteomics Fuel Expanded Communication

Spotlight
Raising the Bar on Tumor Marker Prognostic Studies

Cancer Research Highlights
NCI Analysis Reveals Critical Factors for Minority Trial Recruitment

Study Questions Benefits of Community Screening for Breast Cancer

Genes Involved in Breast Cancer Spread to Lungs Identified

Heat Shock Improves Viral Cancer Therapy

In Stage I Seminomas, Carboplatin Just as Good, If Not Better, Than Radiation

Funding Opportunities

Featured Clinical Trial
Adjuvant Therapy for Patients with Colon Cancer

Notes
Hutchinson's Potter Delivers Annual Cancer Prevention Talk

Tribute to a Tobacco Control Crusader

NCI Listens and Learns

Guest Commentary
Dr. Eddie Reed

Bulletin Archive

Page Options
Print This Page
Print This Document
View Entire Document
E-Mail This Document
View/Print PDF
Funding Opportunities

Featured Meetings and Events
A calendar of scientific meetings and events sponsored by the National Institutes of Health is available at http://calendar.nih.gov/
cgi-bin/calendar
Established Investigator Award in Cancer Prevention & Control
PAR-05-145

Application Receipt Dates: Oct. 1, 2005; Feb. 1, June 1, and Oct. 1, 2006; Feb. 1, June 1, and Oct. 1, 2007; Feb. 1 and June 1, 2008

This is a renewal of PA-03-149. This funding opportunity will use the K05 award mechanism.

For more information see http://cri.cancer.gov/4abst.cfm?initiativeparfa_id=3102.

Inquiries: Dr. Mary Blehar - mblehar@mail.nih.gov

Mentored Patient-Oriented Research Career Development Award (K23)
PA-05-143

Application Receipt Dates: Oct. 1, 2005; Feb. 1, June 1, and Oct. 1, 2006; Feb. 1, June 1, and Oct. 1, 2007; Feb. 1 and June 1, 2008

This is a renewal of PA-00-004. This funding opportunity will use the K23 award mechanism.

For more information see http://cri.cancer.gov/4abst.cfm?initiativeparfa_id=3101.

Inquiries: Dr. Lester Gorelic - gorelicl@mail.nih.gov


The NIH Roadmap for Medical Research Funding provides a framework of the priorities NIH must address to optimize its research portfolio. It identifies the most compelling opportunities in three main areas: new pathways to discovery, research teams of the future, and re-engineering the clinical research enterprise. For information on additional Roadmap funding opportunities, go to http://nihroadmap.nih.gov.

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov